A cluster of noncoding RNAs activates the ESR1 locus during breast cancer adaptation

Nat Commun. 2015 Apr 29:6:6966. doi: 10.1038/ncomms7966.

Abstract

Estrogen receptor-α (ER)-positive breast cancer cells undergo hormone-independent proliferation after deprivation of oestrogen, leading to endocrine therapy resistance. Up-regulation of the ER gene (ESR1) is critical for this process, but the underlying mechanisms remain unclear. Here we show that the combination of transcriptome and fluorescence in situ hybridization analyses revealed that oestrogen deprivation induced a cluster of noncoding RNAs that defined a large chromatin domain containing the ESR1 locus. We termed these RNAs as Eleanors (ESR1 locus enhancing and activating noncoding RNAs). Eleanors were present in ER-positive breast cancer tissues and localized at the transcriptionally active ESR1 locus to form RNA foci. Depletion of one Eleanor, upstream (u)-Eleanor, impaired cell growth and transcription of intragenic Eleanors and ESR1 mRNA, indicating that Eleanors cis-activate the ESR1 gene. Eleanor-mediated gene activation represents a new type of locus control mechanism and plays an essential role in the adaptation of breast cancer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptation, Physiological
  • Base Sequence
  • Breast Neoplasms / metabolism*
  • Carcinoma / metabolism*
  • Estrogen Receptor alpha / genetics
  • Estrogen Receptor alpha / metabolism*
  • Estrogens / deficiency*
  • Female
  • Gene Expression Profiling
  • Gene Expression Regulation / drug effects
  • Humans
  • In Situ Hybridization, Fluorescence
  • MCF-7 Cells
  • Molecular Sequence Data
  • RNA, Untranslated / metabolism*
  • Resveratrol
  • Stilbenes / pharmacology

Substances

  • ESR1 protein, human
  • Estrogen Receptor alpha
  • Estrogens
  • RNA, Untranslated
  • Stilbenes
  • Resveratrol